16.03.2017 • News

Wacker Reduces Stake in Siltronic

“Given the favourable market situation in the semiconductor industry, we saw...
“Given the favourable market situation in the semiconductor industry, we saw an opportunity to significantly reduce Wacker’s stake in Siltronic and, as planned, become a non-controlling shareholder,” said CEO Rudolf Staudigl. Despite the sale, the company remains a major shareholder in Siltronic.

Germany’s Wacker Group has reduced its stake in subsidiary Siltronic from 51.8% to 30.8%. The group sold 6.3 million shares to institutional investors for €55.85 per share, giving gross proceeds of about €352 million.

 “Given the favourable market situation in the semiconductor industry, we saw an opportunity to significantly reduce Wacker’s stake in Siltronic and, as planned, become a non-controlling shareholder,” said CEO Rudolf Staudigl. Despite the sale, the company remains a major shareholder in Siltronic.

In separate news, the Munich-based family-owned chemical producer has announced it will spend about €85 million to build another plant for silicon metal at its site in Holla, Norway. Completion is expected during the first half of 2019.

Wacker also said it will expand its silicone production in Brazil. An investment of around €7 million will be made in a multi-purpose facility to manufacture antifoam compounds and functional silicone fluids at its site in Jandira, near São Paulo.

The silicone fluids reactor is scheduled for completion in the second quarter of 2017 while the antifoam compounds unit is due to go on stream by the end of the year. Wacker said the expansion is in response to growing regional demand for specialty silicones in the textile, paper, household, personal care and cosmetics industries.

Annual capacity figures for both projects were not disclosed.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.